60 likes | 71 Views
High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding scenario, and various technological advancements are key factors contributing to high CAGR of Tumor Ablation during forecast period.
E N D
Market Summary Market Size – USD 973.4 Million in 2018, Market Growth - CAGR of 11.2%, Market Trends – Product launches and research for advanced tumor ablation According to the current analysis of Reports and Data, the global Tumor Ablation market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %. The study covers Tumor Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor. • Further key findings from the report suggest • Tumor Ablation market is growing at a CAGR of 12% in Asia Pacific followed by North America and Europe, with 0% and 10.9% CAGR, respectively. High cancer prevalence across the globe is the major factor driving the market during the forecast period across all regions. • The Radiofrequency Ablation segment dominates the market with a 25% market share. It is also estimated to grow at a CAGR of 10.3% as it is more preferably used for localized tumor ablation surgery especially for malignant liver cancer as it do not require longer period of hospital stay for the pre surgery observations www.reportsanddata.com
Market Summary Key Players: Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc. Segmentation: • Treatment Type Outlook (Revenue, USD Million; 2016-2026) • Surgical Ablation • Laparoscopic Ablation • Percutaneous Ablation • Technology Type Outlook (Revenue, USD Million; 2016-2026) • Radiofrequency Ablation • Cryoablation • Microwave Ablation • Irreversible Electroporation • Other Ablation Technologies Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/2029 www.reportsanddata.com
Market Summary • Application Type Outlook (Revenue, USD Million; 2016-2026) • Liver Cancer • Lung Cancer • Breast cancer • Prostate Cancer • Other Cancer • Regional Outlook for Tumor Ablation Marketanalyses the following geographies: • North America (United States, Canada, and Mexico) • Europe (Germany, France, UK, Russia, and Italy) • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) • South America (Brazil, Argentina, Colombia, etc.) • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Grab Your Report at an Impressive Discount! Please Click Here @https://www.reportsanddata.com/discount-enquiry-form/2029 www.reportsanddata.com
The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com
About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com